新闻动态

3月26-30日，作为全世界三大肝病学会年会之一的第34届亚太肝病学会年会（APASL 2025）在北京国家会议中心召开。我院大内科副主任兼肝胆病科主任汪静教授团队应邀参会。

会上，朱晓宁副教授作了《Efficacy and safety of He-Shu-Xiao-Ji pill combined with standard treatment strategy in HBV-related hepatocellular carcinoma: A single-center, open-label, prospective control, real-world cohort study》口头报告，介绍了我院院内制剂和枢消积丸联合标准治疗方案防治原发性肝癌的标志性研究成果。硕士研究生江媛媛、彭庆华、司马鑫梅分别作了《Profiling the Roles of MicroRNAs Associated with Cancer Stem Cells, Drug Resistance, Metastasis, and Recurrence in Hepatocellular Carcinoma: A Systematic Review, Network analysis, and Experimental Initial Verification》和《The effective ingredients identification and pharmacodynamics exploration of the Qu-Tan-Huo-Xue Formula in the treatment of Non-Alcoholic Fatty Liver Disease》海报展示。

朱晓宁作口头报告

江媛媛作海报展示

彭庆华、司马鑫梅作海报展示